Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression. Founded by Bill Haney and Kathleen McCarthy in 2016Skyhawk Therapeutics is backed by Fidelity Management and Research Company, Alexandria Venture Investments, Good Growth Capital, GreatPoint Ventures, and Celgene and is headquartered in Waltham.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Therapeutics
FOUNDERS:
Bill Haney, Kathleen McCarthy
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
